2023

• Maloney, S., Pavlakis, N., Itchins, M., Arena, J., Mittal, A., Hudson, A., Colvin, E., Sahni, S., Diakos, C., Chan, D., Gill, A., Samra, J., Clarke, S. (2023). The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer. Journal of Clinical Medicine, 12(5). [More Information]

2022

• Colvin, E., Hudson, A., Anderson, L., Kumar, R., McGregor, I., Howell, V., Arnold, J. (2022). An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma. Cancers, 14(15). [More Information]
• Nahm, C., Turchini, J., Sahni, S., Millar, E., Itchins, M., Arena, J., Cho, A., Colvin, E., Howell, V., Pavlakis, N., Clarke, S., Samra, J., Gill, A., Mittal, A. (2022). The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer. Cancers, 14(15). [More Information]

2021

• Sahin, K., Shah, E., Ferguson, G., Molloy, C., Kalita, P., Hayes, S., Hudson, A., Colvin, E., Kamitakahara, H., Harvie, R., Hasovits, C., Howell, V., et al (2021). Elevating CDCA3 levels enhances tyrosine kinase inhibitor sensitivity in TKI-resistant EGFR mutant non-small-cell lung cancer. Cancers, 13(18), 4651. [More Information]

2020

• Colvin, E., Howell, V., Mok, S., Samimi, G., Vafaee, F. (2020). Expression of lncRNAs in cancer-associated fibroblasts linked to patient survival in ovarian cancer. Cancer Science, 111(5), 1805-1817. [More Information]
• Zakarya, R., Howell, V., Colvin, E. (2020). Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches. International Journal of Molecular Sciences, 21(13), 1-15. [More Information]
• Colvin, E., Howell, V. (2020). Why the dual origins of high grade serous ovarian cancer matter. Nature Communications, 11(1), 1-4. [More Information]

2019

• Nahm, C., Turchini, J., Jamieson, N., Moon, E., Sioson, L., Itchins, M., Arena, J., Colvin, E., Howell, V., Pavlakis, N., Clarke, S., Samra, J., Gill, A., Mittal, A. (2019). Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study. European Journal of Surgical Oncology, 45(2), 218-224. [More Information]

2018

• Nahm, C., Brown, K., Townend, P., Colvin, E., Howell, V., Gill, A., Connor, S., Samra, J., Mittal, A. (2018). Acinar cell density at the pancreatic resection margin is associated with post-pancreatectomy pancreatitis and the development of postoperative pancreatic fistula. HPB, 20(5), 432-440. [More Information]
• Pham, B., Colvin, E., Pham, T., Kim, B., Fuller, E., Moon, E., Barbey, R., Yuen, S., Rickman, B., Bryce, N., Howell, V., Hawkett, B., et al (2018). Biodistribution and clearance of stable superparamagnetic maghemite iron oxide nanoparticles in mice following intraperitoneal administration. International Journal of Molecular Sciences, 19(1), 1-23. [More Information]

2017

• Vafaee, F., Colvin, E., Mok, S., Howell, V., Samimi, G. (2017). Functional prediction of long non-coding RNAs in ovarian cancer-Associated fibroblasts indicate a potential role in metastasis. Scientific Reports, 7(1), 1-11. [More Information]

2016

• Hudson, A., Colvin, E. (2016). Transgenic mouse models of SV40-induced cancer. ILAR Journal, 57(1), 44-54. [More Information]

2015

• Moran-Jones, K., Gloss, B., Murali, R., Chang, D., Colvin, E., Jones, M., Yuen, S., Howell, V., Brown, L., Wong, C., et al (2015). Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer. Oncotarget, 6(42), 44551-44562. [More Information]
• Upton, D., Fuller, E., Colvin, E., Walters, K., Jimenez, M., Desai, R., Handelsman, D., Howell, V., Allan, C. (2015). Granulosa Cell-Specific Brca1 Loss Alone or Combined with Trp53 Haploinsufficiency and Transgenic FSH Expression Fails to Induce Ovarian Tumors. Hormones and Cancer, 6(4), 142-152. [More Information]
• Susanto, J., Colvin, E., Pinese, M., Chang, D., Pajic, M., Mawson, A., Caldon, C., Musgrove, E., Henshall, S., Sutherland, R., et al (2015). The epigenetic agents suberoylanilide hydroxamic acid and 5-AZA-2′ deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo. International Journal of Oncology, 46(5), 2223-2230. [More Information]
• Cho, A., Howell, V., Colvin, E. (2015). The extracellular matrix in epithelial ovarian cancer - A piece of a puzzle. Frontiers in Oncology, 5, 1-16. [More Information]

2014

• Colvin, E., Scarlett, C. (2014). A historical perspective of pancreatic cancer mouse models. Seminars in Cell & Developmental Biology, 27, 96-105. [More Information]
• Howell, V., Colvin, E. (2014). Genetically Engineered Insertional Mutagenesis in Mice to Model Cancer: Sleeping Beauty. In Shree Ram Singh, Vincenzo Coppola (Eds.), Mouse Genetics: Methods and Protocols, (pp. 367-383). New York: Springer. [More Information]
• Colvin, E., Weir, C., Ikin, R., Hudson, A. (2014). SV40 TAg mouse models of cancer. Seminars in Cell & Developmental Biology, 27, 61-73. [More Information]
• Colvin, E. (2014). Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Frontiers in Oncology, 4, 1-6. [More Information]

2013

• Wauters, E., Sanchez-Arevalo Lobo, V., Pinho, A., Mawson, A., Herranz, D., Wu, J., Cowley, M., Colvin, E., Njicop, E., Sutherland, R., et al (2013). Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer. Cancer Research, 73(7), 2357-2367. [More Information]

2008

• Colvin, E., Chang, D., Merrett, N., Biankin, A. (2008). Individualizing therapy for pancreatic cancer. Journal of Gastroenterology and Hepatology, 23(12), 1779-82. [More Information]